Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Nonalcoholic Steatohepatitis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT03291249
What this trial is testing

Assessment of the Safety of Foralumab, an Oral Anti-CD3 Antibody, in Patients With NASH and T2DM

Who this might be right for
NASH - Nonalcoholic SteatohepatitisNAFLDT2DM (Type 2 Diabetes Mellitus)
Tiziana Life Sciences LTD
Testing effectiveness (Phase 2)Study completedNCT01147523
What this trial is testing

Effect of Spironolactone and Vitamin E in Patients With Nonalcoholic Fatty Liver Disease

Who this might be right for
Fatty LiverSteatohepatitis
Aristotle University Of Thessaloniki 30
Large-scale testing (Phase 3)Looking for participantsNCT07581951
What this trial is testing

Study Evaluating the Safety and Efficacy of HSK31679 in Patients With MASH

Who this might be right for
MASH - Metabolic Dysfunction-Associated SteatohepatitisNASH (Non-Alcoholic Steatohepatitis)
Haisco Pharmaceutical Group Co., Ltd. 886
Not applicableUnknownNCT05358496
What this trial is testing

Study of Neutrophils and Circulating Platelets in Correlation With the Activity of T Lymphocytes in Patients With NAFLD (Nonalcoholic Fatty Liver Disease)

Who this might be right for
NAFLD- Non Alcoholic Fatty Liver Disease
University of L'Aquila 80
Post-approval studies (Phase 4)Study completedNCT00160407
What this trial is testing

Orlistat (Xenical) in the Treatment of Overweight Patients With Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Fatty LiverHepatitis
St. Louis University 50
Testing effectiveness (Phase 2)Study completedNCT04555434
What this trial is testing

Effects of Probiotics (P. Pentosaceus, L. Lactis or L. Helveticus) in NASH

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseMASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease
Chuncheon Sacred Heart Hospital 89
Early research (Phase 1)Study completedNCT06044467
What this trial is testing

The Study of Multiple Doses of CM-101 in Male and Female NAFLD (Nonalcoholic Fatty Liver Disease) and NAFLD/NASH (Nonalcoholic Steatohepatitis) Subjects

Who this might be right for
Nonalcoholic Fatty Liver Disease
ChemomAb Ltd. 16
Testing effectiveness (Phase 2)Study completedNCT04140123
What this trial is testing

Tolerability, Efficacy, and PK of ZSP1601 in Patients With Non-Alcoholic Steatohepatitis (NASH)

Who this might be right for
Non-Alcoholic Steatohepatitis (NASH)
Guangdong Raynovent Biotech Co., Ltd 37
Not applicableUnknownNCT00247117
What this trial is testing

Metformin in Patients With Non-Alcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Liver Diseases
Kaplan Medical Center 15
Not applicableUnknownNCT02488941
What this trial is testing

Mapping of Metabolic Liver Functions in Patients With Non-alcoholic Fatty Liver Disease

Who this might be right for
Non-alcoholic Fatty Liver Disease
University of Aarhus 30
Testing effectiveness (Phase 2)Study completedNCT04771273
What this trial is testing

Test Safety and Efficacy of Survodutide (BI456906) in Adults With Non-alcoholic Steatohepatitis (NASH) and Fibrosis (F1-F3)

Who this might be right for
Non-alcoholic Steatohepatitis (NASH)
Boehringer Ingelheim 295
Not applicableLooking for participantsNCT07068191
What this trial is testing

Gepaktiv vs UDCA and Ademetionine in MAFLD With Hepatomegaly

Who this might be right for
Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)HepatomegalyNonalcoholic Fatty Liver (NAFL)+5 more
Phenomen Pharma 90
Post-approval studies (Phase 4)Study completedNCT05898841
What this trial is testing

Study to Evaluate the Efficacy and Safety of a Rilpivarine-based Antiretroviral Tratment Regimen in HIV- Infected Patients With Liver Metabolic Disease Who Maintain Udetectable HIV Viral Load

Who this might be right for
HIV InfectionsFatty Liver Disease
Fundacion SEIMC-GESIDA 63
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07632222
What this trial is testing

High-Protein Diet for Improving Alcoholic Fatty Liver Disease

Who this might be right for
Alcohol-associated Fatty Liver Disease
Li Lab,MD 74
Testing effectiveness (Phase 2)Study completedNCT05824156
What this trial is testing

CM-101 in NASH Patients - The SPLASH Study

Who this might be right for
Nonalcoholic Steatohepatitis
ChemomAb Ltd. 23
Post-approval studies (Phase 4)Study completedNCT02331589
What this trial is testing

Anti-fatigue Effect of Korean Red Ginseng in Patients With Non-alcoholic Hepatitis

Who this might be right for
Fatigue
Chuncheon Sacred Heart Hospital 75
Early research (Phase 1)Ended earlyNCT00808990
What this trial is testing

The Effect of Probiotics on Non Alcoholic Fatty Liver Disease

Who this might be right for
Liver Disease
Rabin Medical Center 38
Testing effectiveness (Phase 2)Active Not RecruitingNCT04679376
What this trial is testing

Statins for the Treatment of NASH

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Mayo Clinic 70
Testing effectiveness (Phase 2)UnknownNCT04702490
What this trial is testing

Study to Evaluate MET409 Alone or in Combination With Empagliflozin in Patients With Type 2 Diabetes and NASH

Who this might be right for
NASHNASH - Nonalcoholic SteatohepatitisType 2 Diabetes+5 more
Metacrine, Inc. 120
Testing effectiveness (Phase 2)Study completedNCT03205150
What this trial is testing

Effect of LIK066 on Reduction of Fatty Content in Livers of Obese Patients

Who this might be right for
Obese Patients With Non-alcoholic Steatohepatitis (NASH)
Novartis Pharmaceuticals 107
Next Page